ClinicalTrials.Veeva

Menu

The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease

A

Assiut University

Status

Completed

Conditions

Pulmonary Hypertension
Interstitial Lung Disease

Treatments

Diagnostic Test: Pulmonary function test

Study type

Observational

Funder types

Other

Identifiers

NCT03396120
AssiutU6

Details and patient eligibility

About

Pulmonary hypertension (PH) is a common disorder among patients with interstitial lung disease (ILD). The symptoms are usually nonspecific and overlooked. Thus, a noninvasive screening modality is recommended for early detection of PH because of its potentially significant impact on treatment strategy and clinical outcomes.

Objectives: To evaluate the usefulness of assessing forced vital capacity (FVC%), diffusion capacity of the lung for carbon monoxide (DLCO%), and FVC%/DLCO% ratio to predict pulmonary hypertension among patients with ILDs.

Enrollment

95 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • This retrospective study included all patients diagnosed with interstitial lung disease (ILD) who were followed up by the chest department of a tertiary hospital between September 2016 and January 2017

Exclusion criteria

  • patients with occupational history
  • collagen vascular disease predisposing them to lung disorders
  • patients who could not undergo pulmonary function testing

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems